about
Surgery for local and locally advanced non-small cell lung cancerConcurrent chemoradiotherapy in non-small cell lung cancerSurgery for early stage non-small cell lung cancerRole of postoperative radiotherapy in resected non-small cell lung cancer: a reassessment based on new dataStaging lymph node metastases from lung cancer in the mediastinumXPC mRNA level may predict relapse in never-smokers with non-small cell lung cancersAdjuvant chemotherapy for T1-2NOMO small cell lung cancer: single-agent or combination chemotherapy?FHIT and p53 gene abnormalities in bronchioloalveolar carcinomas. Correlations with clinicopathological data and K-ras mutations.Increasing dose intensity of cisplatin-etoposide in advanced nonsmall cell lung carcinoma: a phase III randomized trial of the Spanish Lung Cancer Group.A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.acp. Best practice no 161. Examination of lung specimens.A phase II study of cisplatin, vindesine and continuously infused 5-fluorouracil in the treatment of advanced non-small-cell lung cancer. Osaka Lung Cancer Chemotherapy Study GroupPhase I study of accelerated conformal radiotherapy for stage I non-small-cell lung cancer in patients with pulmonary dysfunction: CALGB 39904.A pilot trial of serial 18F-fluorodeoxyglucose positron emission tomography in patients with medically inoperable stage I non-small-cell lung cancer treated with hypofractionated stereotactic body radiotherapyRole of adjuvant radiotherapy in completely resected non-small-cell lung cancer.High dose rate brachytherapy for the local control of endobronchial carcinoma following external irradiation.The prognostic impact of supraclavicular lymph node in N3-IIIB stage non-small cell lung cancer patients treated with definitive concurrent chemo-radiotherapy.Emphysema as a risk factor for the outcome of surgical resection of lung cancer.C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas.Lung cancer--bad news, good newsAlterations of P16 (MTS1) in node-positive non-small cell lung carcinomas.Bevacizumab: the evidence for its clinical potential in the treatment of nonsmall cell lung cancer.Minimal residual disease in non-small-cell lung cancer.Extracranial stereotactic radiation delivery: expansion of technology beyond the brain.Levels of recombinant human granulocyte colony-stimulating factor in serum are inversely correlated with circulating neutrophil counts.Important prognostic factors for survival in patients with malignant pleural effusion.Functional imaging in lung cancerConcomitant cardiac and pulmonary operations for lung cancer.Update on anti-angiogenic therapy in non-small cell lung cancer: Are we making progress?Role of p27Kip1 and cyclin-dependent kinase 2 in the proliferation of non-small cell lung cancer.Oral nutritional supplements containing n-3 polyunsaturated fatty acids affect quality of life and functional status in lung cancer patients during multimodality treatment: an RCT.Mutational spectrum of the p53 gene in human small-cell lung cancer and relationship to clinicopathological data.Immunohistochemical study of p53 in human lung carcinomas.Chemotherapy Treatment of Elderly Patients (≥70 Years) with Non-Small Cell Lung Cancer: A Seven-Year Retrospective Study of Real-Life Clinical Practice at Karolinska University Hospital, SwedenA comparison of serum CYFRA 21-1 and SCC Ag in the diagnosis of squamous cell lung carcinoma.Phase I and pharmacologic study of irinotecan in combination with cisplatin for advanced lung cancer.Measurement of cytokeratin 19 fragments as a marker of lung cancer by CYFRA 21-1 enzyme immunoassay.A phase II trial of combination of CPT-11 and cisplatin for advanced non-small-cell lung cancer. CPT-11 Lung Cancer Study Group.Genetic analysis of lung tumours of non-smoking subjects: p53 gene mutations are constantly associated with loss of heterozygosity at the FHIT locus.Prognostic value of replication errors on chromosomes 2p and 3p in non-small-cell lung cancer.
P2860
Q24245182-B125C27C-8A9A-4F94-AABF-46E1B341AF88Q24245635-B4C6C847-44AD-4A6C-BD55-D778DFF8B754Q24247318-DBAC350E-AA32-4D7C-9B82-6EF3355FCFD3Q24633254-E603B62A-8979-47B9-9294-F3FDDA228652Q26863443-755179CD-AA60-483B-90EF-2F566C641814Q28246216-B07748B8-3FA7-40F3-9EAA-99ADFCA04B89Q28327044-3F8809A0-C9B0-4BA6-99FB-08526A735ADCQ32061854-7D0A4AE8-2B87-4601-886D-052AD567863EQ33328264-1008EE0A-A088-4873-BD84-1FB6243AA755Q33331232-466E4BC5-3B39-4DEC-9A7B-4DF3D703A74AQ33389621-86D8BAAC-D0A9-4B17-85E4-6144F4BC5AE4Q33495664-F8BF06D5-356A-4EB5-8B76-F888A924FC09Q33627751-ADBE2987-E5EB-4ADD-91E2-D13C3A0CE8CAQ33664774-9027575F-1216-4EAD-8A95-38F64C8AA5D8Q33698439-BCC80365-A984-468B-869C-923C001801ACQ33775974-36905926-DADA-41DA-85EA-FEC556DE12ABQ33829279-A77637D0-EB16-4664-9A16-19A600D3548FQ34014738-3FBE8DD9-D1E5-488D-871F-F1580C5B3692Q34124421-021A644B-8908-4AEF-AB54-E2A5B48EFE32Q34194023-72804E43-6360-439D-AD8F-80C0F5FD2827Q34423364-4FD0D1FB-3EC1-47C6-AD0A-2DA8E73AD591Q34450520-2FDD3B6C-7388-47BA-920D-7247D8F33139Q34465186-F6D81C82-2AD4-4DFC-9008-8C7CDAE5BE92Q35101606-5BAF03CA-EFF5-478F-8654-8B586EBA9D59Q35123826-8782F2F3-B477-47D3-9566-59B955BCD335Q35232954-1B551482-E66B-4505-B7C6-8697C42ADE8BQ35550676-E16B8671-4FB5-462B-B293-530712B23DC1Q35657192-058E0803-4942-4D02-B1B3-0E30DB07CCAEQ35667802-006FA5F9-CE29-4DF4-B7A5-259359C9F7B9Q35753272-E7783C20-7273-45F8-86DC-8D62A68BC113Q35828425-A7BDBC86-9E60-48B3-B1B0-F4F2B3D9EFE0Q35832451-D8E3BF72-69F1-434D-9CC9-F3305772DF5FQ35832962-D355A14F-62C4-49FD-8386-ED2992A42AC7Q35896484-3A8DADD5-C9E6-4AD2-BC9B-2F4ADFE5CE7AQ35938690-FAACFDB0-D6F4-4498-97DB-A44EF7CC94A2Q35977364-0E036DFC-14A2-42A8-B333-9F0DF66AC33EQ36079799-3EA8DF5E-313B-4422-A662-A1A7779D782BQ36114656-CA46E8B6-676B-4CA5-972A-BDF2BD0E4659Q36114860-8069D253-F546-4B7B-ADE1-5F33E8614492Q36115963-2C9EFCB8-B232-411B-A7B1-CCF764084652
P2860
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
A new international staging system for lung cancer.
@en
A new international staging system for lung cancer.
@nl
type
label
A new international staging system for lung cancer.
@en
A new international staging system for lung cancer.
@nl
prefLabel
A new international staging system for lung cancer.
@en
A new international staging system for lung cancer.
@nl
P1433
P1476
A new international staging system for lung cancer.
@en
P2093
Mountain CF
P304
P356
10.1378/CHEST.89.4_SUPPLEMENT.225S
P407
P433
P577
1986-04-01T00:00:00Z